Population- based cancer survival estimates

Similar documents
Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

7/11/2011. The impact of cancer survival studies on health policy. NCI prevention budget falls. Cases Deaths Survivors

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million

Differences make a Difference

Cancer incidence, mortality and survival for health policy and cancer control

World Connections Committee (WCC) Report

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

CONCORD Programme: Worldwide Surveillance of Cancer Survival. The US Perspective

Main developments in past 24 hours

The health economic landscape of cancer in Europe

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 HUNGARY

FACTS FIGURES A FUTURE

WCPT COUNTRY PROFILE December 2017 SERBIA

3.1 PHASE 2 OF THE GLOBAL PROJECT

Extract from Cancer survival in Europe by country and age: results of EUROCARE-5 a population-based study

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Enriched RWE study in the Nordics a case study

CND UNGASS FOLLOW UP

Access to treatment and disease burden

Global EHS Resource Center

Country-wise and Item-wise Exports of Animal By Products Value Rs. Lakh Quantity in '000 Unit: Kgs Source: MoC Export Import Data Bank

Smokefree Policies in Europe: Are we there yet?

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

Terms and Conditions. VISA Global Customer Assistance Services

ETB Data. there was. compared

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

Engagement in language assessment / Regions of Europe

Allied Health: Sustainable Integrated Health Care for all Australians

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG-SAFE)

Alcohol-related harm in Europe and the WHO policy response

Table 7.1 Summary information for lung cancer in Ireland,

Current levels and recent trends in health inequalities in the EU: Updates from the EU Report

Global Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd ( Page 1 5/18/2015

Emily J. Hadgkiss, 1 George A. Jelinek, 1,2 Tracey J. Weiland, 1,3 Naresh G. Pereira, 4 Claudia H. Marck, 1 and Dania M.

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT

- Network for Excellence in Health Innovation

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

Overview of drug-induced deaths in Europe - What does the data tell us?

Recommended composition of influenza virus vaccines for use in the 2007 influenza season

ESPEN Congress Geneva 2014 FOOD: THE FACTOR RESHAPING THE SIZE OF THE PLANET

HPV Vaccines: Background and Current Status

European status report on alcohol and health Leadership, awareness and commitment

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

The Risk of Alcohol in Europe. Bridging the Gap June 2004

Monthly measles and rubella monitoring report

Country Length Discount Travel Period Anguilla All 20% off 08/24/11 12/15/11 Antigua All 20% off 08/24/11 12/15/11 Argentina All 20% off 08/24/11

Table 9.1 Summary information for stomach cancer in Ireland,

11 Melanoma of the skin

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

The cancer burden in the European Union and the European Region: the current situation and a way forward

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017

European Association of Dental Public Health Prevention of Oral Cancer

Rheumatoid Arthritis Disease Burden and Access to Treatment

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

UK bowel cancer care outcomes: A comparison with Europe

European Collaboration on Dementia. Luxembourg, 13 December 2006

Summary of Results for Laypersons

VIRUS VACCINES & CANCER a story with two chapters

BACKGROUND AND RATIONALE

Where we stand in EFORT

Weekly Influenza Surveillance Report. Week 11

Appendix F: Test-Curriculum Matching Analysis

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

of the Bone and Joint Decade The Global Challenge of Fragility Fractures and the Role of Fragility fracture Network

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

Available Hepatitis Information: how can this be used to convince decision makers and potential funders

Design and Analysis of a Cancer Prevention Trial: Plans and Results. Matthew Somerville 09 November 2009

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

A Summary of Childhood Cancer Statistics in Australia,

The Economics of Tobacco Control and Tobacco Taxation: Challenges & Opportunities for a Tobacco Free Turkey

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

Shigellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Cancer in transition: the human development index and the global disease burden 2008 and Freddie Bray

25 September 2012 Early Years Pathfinder. misuse. Insert name of presentation on Master Slide. Presenter: Dr Sarah J Jones

Screening for Cervical Cancer in Europe

Appendix F. The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479

ILO Background: List of Occupational Diseases

COMMISSION OF THE EUROPEAN COMMUNITIES

Table 6.1 Summary information for colorectal cancer in Ireland,

Injection Techniques Questionnaire (ITQ) WorldWide Results Needle Gauge

Prevention of Oral Cancer Special Interest Working Group

Real Life, Real PD Survey

Cancer Mortality by Country of Birth, Sex, and Socioeconomic Position in Sweden,

Transcription:

Population- based cancer survival estimates Represent average prognosis of cancer in a specific population Socio-economic features Health care seeking behaviours Coverage and quality of health care services Evaluate progress in cancer control Evaluate differences in equity when done in a comparative way

Country Income Groups (World Bank Classification) High Income, GNI per capita (US$): 12,196 or more Upper Middle Income, GNI (US$): 3,946-12,195 Lower Middle Income, GNI (US$): 995-3,945 Low Income, GNI (US$): below 995 http://chartsbin.com/view/e2x

Country Gini Coefficient (UN) UN Human Development Report 2007/2008

Cancer burden according to income No. High Income Countries Low - Middle Income Countries Site Cases ASR Deaths ASR M/I Site Cases ASR Deaths ASR M/I 1 Colorrect 728,550 30.1 320,279 12 0.40 Lung 884,359 19.1 777,953 16.8 0.88 2 Lung 723,696 31.3 598,626 24.8 0.79 Stomach 713,907 15.3 556,471 11.9 0.78 3 Breast 692,634 66.4 189,455 15.3 0.23 Breast 691,521 27.3 269,048 10.8 0.40 4 Prostate 644,044 61.7 136,238 10.5 0.17 Liver 626,548 13.1 580,440 12.2 0.93 5 Stomach 274,695 11.4 180,948 7.2 0.63 Colorrecta 506,558 10.7 288,772 6.1 0.57 Globocan 2008, IARC, Lyon

Comparative cancer survival studies in LMIC LSHTM - Institution, Study and No. of cancer registries involved LMI Country IARC 1 IARC 2,3 CONCORD 4 ISS -ROME 5 Asia China 2 4 India 4 5 Pakistan 1 Philippines 1 2 Thailand - 2 4 Africa Algeria 1 The Gambia 1* Uganda 1 Zimbawe 1 Europa Estonia 1* Poland** 2 Turkey 1 Latin America Cuba 1* 1* 1* Costa Rica 1* Brazil 2 1 Total Countries and registries 5 (10) 11 (21) 5 (7) 1 * National Cancer Registry ** LMIC before 2008 1. Sankaranarayanan R, et al IARC Scientific Publ 145; 1998 / 2. Sankaranarayanan R, et al. Lancet Oncol 2010; 11: 165 73 3. Sankaranarayanan R, et al. SurvCan IARC Scientific Publications volume 162, 2011 / 4. Coleman M, et al Lancet Oncol 2008; 9: 730 5 / 5. Verdecchia et al. Eur Journal of Cancer 2003; 39: 1603 1609

Collaborative survival studies in LMIC Key issues 1. Building local capacity for survival surveillance Training Timeliness 2. Comparability 3. Visibility 4. Monitoring progress of cancer control

1. Building local capacity Registry Vol. I Vol. II Vol. III Vol. IV Vol. V Vol. VI Vol. VII Vol. VIII Vol. IX Cali 1962-64 1962-66 1967-71 1972-76 1977-81 1982-86 1987-91 1992-96 1998-2002 1 Campinas - - - - - - - 1991-95 - 2 Chennai - - - - 1982 1983-87 1988-92 1993-97 1998-2002 3 Barshi - - - - - - 1988-92 - - 3 The Gambia - - - - - 1987-89 - 1997-98 - 4 Non- collabora+vesurvival study Collabora+ve survival studies 1. Bravo LE, et al. Supervivencia ca Cuello; supervivencia en niños. Informes al INC, 2007-2008 2. Coleman M, et al Lancet Oncol 2008; 9: 730 56 3. Sankaranarayanan R et al IARC Scientific Publ 145 4. Sankaranarayanan R et al Lancet Oncol 2010; 11: 165 73

2. Comparability Comparisons between countries Same methods and standards Raise awareness on differences and inequali8es Five- year rela+ve survival (%) - breast cancer, women (15-99 years) 0 20 40 60 80 100 CUBA 1.0 * USA 5.6 CANADA SWEDEN JAPAN AUSTRALIA FINLAND FRANCE ITALY 41.7 ICELAND SPAIN NETHERLANDS NORWAY SWITZERLAND GERMANY AUSTRIA DENMARK MALTA PORTUGAL N IRELAND SCOTLAND ENGLAND IRELAND 50.7 WALES SLOVENIA POLAND CZECH REP. ESTONIA BRAZIL SLOVAKIA ALGERIA BREAST (F) Coleman M, et al Lancet Oncol 2008; 9: 730 56

2. Comparability countries countries Raise awareness on differences and inequali8es Childhood Childhood cancer survival by Socioeconomic Classification of Housing, Cali, Colombia 1994-2003. Highest Medium years Lower medium Lowest Bravo LE, et al. Cáncer infantil en Cali Colombia 1994-2003 U

3. Visibility

4. Monitoring progress in cancer control Two-Year Event-free Survival Rates among Children with Acute Lymphoblastic Leukemia Treated in a Public Hospital in Recife, Brazil. Ribeiro R. Improving Childhood cancer treatment in developing countries NEJM 2005; 352: 2158-2160

CONCORD- 2 and information for LMIC World Bank Registered* Probable** Countries Registries Countries Registries Upper Middle 17 41 2 15 Lower Middle 3 3 1 5 Low 3 3 1 0 LMIC 23 47 4 20 Registered, August 2012 Approved but not registered

Final considera8ons Survival as a tool for comprehensive cancer control plans Define strategies and plans Evaluate strategies and plans Survival as an outcome measure for the UN Summit on NCDs